首页 › 肝癌（肝细胞癌） › 威斯康星州 › Milwaukee
Milwaukee WI 肝癌（肝细胞癌）临床试验
8项针对 肝癌（肝细胞癌）的研究正在 Milwaukee及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中欢迎健康志愿者
- Zablocki Veterans Administration Medical Center, Milwaukee
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #33, Milwaukee
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
招募中3 期
- Research Site, Milwaukee
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
招募中1 期
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
招募中3 期
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 距离 11 英里
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 距离 11 英里
- 以及另外 3 项
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
招募中2 期
- Froedtert and the Medical College of Wisconsin LAPS, Milwaukee
- Medical College of Wisconsin, Milwaukee
Combination of TATE and PD-1 Inhibitor in Liver Cancer
招募中2 期
- Medical College of Wisconsin, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Milwaukee
其他城市的 肝癌（肝细胞癌）试验
- Houston, TX31 项研究
- New York City, NY24 项研究
- Dallas, TX19 项研究
- Los Angeles, CA19 项研究
- Boston, MA18 项研究
- Cleveland, OH18 项研究
- Chicago, IL16 项研究
- Philadelphia, PA16 项研究
- Pittsburgh, PA15 项研究
- San Francisco, CA14 项研究
- Orange, CA14 项研究
- Jacksonville, FL14 项研究
Milwaukee的其他研究
- 乳腺癌23 项研究
- 癌症（所有类型）22 项研究
- 非小细胞肺癌22 项研究
- 多发性骨髓瘤21 项研究
- 肺癌21 项研究
- 前列腺癌20 项研究
- 滤泡性淋巴瘤19 项研究
- 非霍奇金淋巴瘤18 项研究
- 胰腺癌18 项研究
- 急性髓系白血病17 项研究
- 卵巢癌17 项研究
- 弥漫性大B细胞淋巴瘤16 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。